CMPX251121P00001000 Option on Compass Therapeutics
| CMPX Stock | USD 3.48 0.04 1.16% |
CMPX251121P00001000 is a PUT option contract on Compass Therapeutics' common stock with a strick price of 1.0 expiring on 2025-11-21. The contract was not traded in recent days and, as of today, has 73 days remaining before the expiration. The option is currently trading at an ask price of $0.1. The implied volatility as of the 9th of September is 73.0.
A put option written on Compass Therapeutics becomes more valuable as the price of Compass Therapeutics drops. Conversely, Compass Therapeutics' put option loses its value as Compass Stock rises.
Rule 16 of 2025-11-21 Option Contract
The options market is anticipating that Compass Therapeutics will have an average daily up or down price movement of about 0.0% per day over the life of the option. With Compass Therapeutics trading at USD 3.48, that is roughly USD 0.0. If you think that the market is fully understating Compass Therapeutics' daily price movement you should consider buying Compass Therapeutics options at that current volatility level of 0.0%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Out Of The Money Put Option on Compass Therapeutics
An 'Out of The Money' option on Compass has a strike price that Compass Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for Compass Therapeutics' 'Out of The Money' options include buying the options if you expect a big move in Compass Therapeutics' stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.
| Put Contract Name | CMPX251121P00001000 |
| Expires On | 2025-11-21 |
| Days Before Expriration | 73 |
| Open Interest | 33 |
| Strike Price | 1.0 |
| Last Traded At | 0.1 |
| Current Price Spread | 0.0 | 0.1 |
Compass long PUT Option Payoff at expiration
Put options written on Compass Therapeutics grant holders of the option the right to sell a specified amount of Compass Therapeutics at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Compass Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Compass Therapeutics is like buying insurance aginst Compass Therapeutics' downside shift.
Profit |
| Compass Therapeutics Price At Expiration |
Compass short PUT Option Payoff at expiration
By selling Compass Therapeutics' put option, the investors signal their bearish sentiment. A short position in a put option written on Compass Therapeutics will generally make money when the underlying price is above the strike price. Therefore Compass Therapeutics' put payoff at expiration depends on where the Compass Stock price is relative to the put option strike price. The breakeven price of 1.0 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Compass Therapeutics' price. Finally, at the strike price of 1.0, the payoff chart is constant and positive.
Profit |
| Compass Therapeutics Price At Expiration |
Compass Therapeutics Available Put Options
Compass Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Compass. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Compass. It also shows strike prices and maturity days for a Compass Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
| Open Int | Strike Price | Current Spread | Last Price | |||
Put | CMPX251121P00007000 | 0 | 7.0 | 1.2 - 4.8 | 1.2 | In |
Put | CMPX251121P00006000 | 0 | 6.0 | 2.1 - 4.2 | 2.1 | In |
Put | CMPX251121P00005000 | 0 | 5.0 | 0.45 - 3.6 | 0.45 | In |
Put | CMPX251121P00004000 | 4 | 4.0 | 0.0 - 1.45 | 0.8 | In |
Put | CMPX251121P00003000 | 0 | 3.0 | 0.0 - 0.9 | 0.9 | |
Put | CMPX251121P00002000 | 1 | 2.0 | 0.0 - 0.9 | 0.9 | Out |
Put | CMPX251121P00001000 | 33 | 1.0 | 0.0 - 0.1 | 0.1 | Out |
Compass Therapeutics Corporate Management
| Susan Kalled | Chief Officer | Profile | |
| MD MBA | Chief Officer | Profile | |
| Barry JD | Chief Officer | Profile | |
| Neil CPA | Senior Officer | Profile | |
| Peter Moesta | Interim CMC | Profile | |
| Anna Gifford | Communications Manager | Profile |
Additional Tools for Compass Stock Analysis
When running Compass Therapeutics' price analysis, check to measure Compass Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Therapeutics is operating at the current time. Most of Compass Therapeutics' value examination focuses on studying past and present price action to predict the probability of Compass Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Therapeutics' price. Additionally, you may evaluate how the addition of Compass Therapeutics to your portfolios can decrease your overall portfolio volatility.